Richard J Rodeheffer
Overview
Explore the profile of Richard J Rodeheffer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
116
Citations
6933
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Young K, Rodeheffer R, Bird J, Miranda W, Chen H, Oh J, et al.
J Am Soc Echocardiogr
. 2025 Jan;
PMID: 39824232
Background: Abnormalities of left ventricular diastolic function are established independent predictors of heart failure and mortality. The aim of this study was to determine whether the association of diastolic function...
2.
Churchill R, Gochanour B, Scott C, Vasile V, Rodeheffer R, Meeusen J, et al.
Biomarkers
. 2024 Apr;
29(4):161-170.
PMID: 38666319
Materials And Methods: The study assessed major adverse cardiac events (MACE) (myocardial infarction, coronary artery bypass graft, percutaneous intervention, stroke, and death. Cox proportional hazards models assessed apolipoprotein AI (ApoA1),...
3.
Inglis S, Asleh R, Iyer V, Schettle S, Spencer P, Villavicencio M, et al.
Artif Organs
. 2023 Dec;
48(6):646-654.
PMID: 38131635
Background: Gastrointestinal bleeding (GIB) in patients with continuous flow left ventricular assist devices (CF-LVADs) is often related to GI angiodysplasia (GIAD). We previously reported data on VEGF inhibition with IV...
4.
Ammar K, Rodeheffer R
Ann Noninvasive Electrocardiol
. 2023 Sep;
28(6):e13088.
PMID: 37706576
Background: Silent or unrecognized myocardial infarction (UMI) diagnosed by surveillance electrocardiography (ECG) carries similarly poor prognosis as recognized MI (RMI) for poorly understood reasons. Methods: This study included 5430 consecutive...
5.
Ichiki T, Cannone V, Scott C, Iyer S, Sangaralingham S, Bailey K, et al.
Am J Physiol Heart Circ Physiol
. 2023 Jul;
325(3):H545-H552.
PMID: 37417873
Atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) are produced in the heart and secreted into the circulation. As hormones, both peptides activate the guanylyl cyclase receptor A (GC-A),...
6.
Young K, Scott C, Rodeheffer R, Chen H
J Am Heart Assoc
. 2022 Jul;
11(15):e025519.
PMID: 35862175
Background A high prevalence of preclinical heart failure (HF) (Stages A and B) has previously been shown. The aim of this study was to explore factors associated with the incidence...
7.
Kashou A, Medina-Inojosa J, Noseworthy P, Rodeheffer R, Lopez-Jimenez F, Attia I, et al.
Mayo Clin Proc
. 2021 Jun;
96(10):2576-2586.
PMID: 34120755
Objective: To validate an artificial intelligence-augmented electrocardiogram (AI-ECG) algorithm for the detection of preclinical left ventricular systolic dysfunction (LVSD) in a large community-based cohort. Methods: We identified a randomly selected...
8.
Young K, Scott C, Rodeheffer R, Chen H
Circ Cardiovasc Qual Outcomes
. 2021 May;
14(5):e007216.
PMID: 33951931
Background: The aims of this study are to evaluate the rate of progression of preclinical (Stage A and B) heart failure, identify associated characteristics, and evaluate long-term outcomes. Methods: Retrospective...
9.
Daly R, Rosenbaum A, Dearani J, Clavell A, Pereira N, Boilson B, et al.
J Am Coll Cardiol
. 2021 Mar;
77(10):1331-1340.
PMID: 33706876
Background: In patients undergoing heart transplantation, significant allosensitization limits access to organs, resulting in longer wait times and high waitlist mortality. Current desensitization strategies are limited in enabling successful transplantation....
10.
Eiger D, Ponde N, Agbor-Tarh D, Moreno-Aspitia A, Piccart M, Hilbers F, et al.
Br J Cancer
. 2020 Mar;
122(10):1453-1460.
PMID: 32203207
Background: Cardiotoxicity is the most significant adverse event associated with trastuzumab (T), the main component of HER2-positive breast cancer (BC) treatment. Less is known about the cardiotoxicity of dual HER2...